Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
Arnd
A
Gandorfer
Anselm
A
Kampik
D000818:Animals; D004789:Enzyme Activation; D005341:Fibrinolysin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007150:Immunohistochemistry; D007267:Injections; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D011817:Rabbits; D012160:Retina / Q000201:enzymology; D014821:Vitrectomy; D014822:Vitreous Body / Q000187:drug effects* / Q000201:enzymology*
D005343:Fibrinolytic Agents; D005341:Fibrinolysin; D020778:Matrix Metalloproteinase 2